No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Guangdong Lifestrong Pharmacy to Raise Stake in Wannianqing Pharma to Nearly 93%
Yue Jiangxi Wannianqing Cement (301111.SZ) plans to increase investment in its controlling subsidiary Jiangxi Wannianqing Cement Pharmaceutical by 22.8 million yuan.
Yue Jiangxi Wannianqing Cement (301111.SZ) issued an announcement that its controlling subsidiary, Guangdong Jiangxi Wannianqing Pharmaceutical Co., Ltd. (the following...)
Guangdong Wannianqing: 2024 Annual Results Forecast
Are Guangdong Lifestrong Pharmacy Co., Ltd.'s (SZSE:301111) Mixed Financials Driving The Negative Sentiment?
Yue Jiangxi Wannianqing Cement (301111.SZ): Currently, there is no production or sales of Pharmaceuticals for the treatment of monkeypox.
On January 13, Gelonghui reported that Jiangxi Wannianqing Cement (301111.SZ) stated on the investor interaction platform that the company currently does not produce or sell any Pharmaceuticals for the treatment of monkeypox.
There's Reason For Concern Over Guangdong Lifestrong Pharmacy Co., Ltd.'s (SZSE:301111) Massive 38% Price Jump
